Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems


Sarandol A., Sarandol E. , Eker S. S. , Erdinc S., Vatansever E., Kirli S.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, vol.22, no.2, pp.67-73, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 2
  • Publication Date: 2007
  • Doi Number: 10.1002/hup.829
  • Title of Journal : HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
  • Page Numbers: pp.67-73
  • Keywords: major depressive disorder, oxidative stress, antidepressant treatment, venlafaxine, sertraline, reboxetine, LIPID-PEROXIDATION, NITRIC-OXIDE, SERUM VITAMIN, LOW-DENSITY, PLASMA, DAMAGE

Abstract

Objective The aim of the present study was to investigate the oxidative-antioxidative systems and effects of different antidepressants on these systems in patients with major depressive disorder (MDD).